Loading provider…
Loading provider…
Gastroenterology Physician in Reading, PA
NPI: 1023148731Primary Practice Location
Berks Center for Digestive Health, LP
1030 Reed Ave, Reading, PA
Primary Employer
Mid-Atlantic Endoscopy, LLC
midatlanticendoscopycenter.com
HQ Phone
Get MD, MPH Nirav's Phone Numberphone_androidMobile
Get MD, MPH Nirav's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 132 | 156 |
| 2 | 43239Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | 112 | 116 |
| 3 | 45385Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 79 | 80 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 74 | 76 |
| 5 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 45 | 45 |
Biosemantics guided gene expression profiling of Sjögren's syndrome: a comparative analysis with systemic lupus erythematosus and rheumatoid arthritis.
Authors: Nirav Shah, Braxton Noll, Craig Stevens, Michael Brennan, Farah Mougeot, Jean-luc Mougeot
Publication Date: 2016-10-18
Expression of ETS1 and LEF1 in salivary glands of Sjögren syndrome patients.
Authors: Nirav Shah, Braxton Noll, Ricardo Padilla, Mike Brennan, Farah Mougeot, Jean-luc Mougeot
Publication Date: 2018-06-12
Authors: Cataldi, Marcela, Shah, Nirav R, Felt, Sébastien A, Grdzelishvili, Valery Z
Journal: Virology
Publication Date: 2015-08-29
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Mirikizumab
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo SC, DRUG: Mirikizumab SC, DRUG: Mirikizumab IV
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Mirikizumab